Evaluation of the Anti-Adenoviral Activity of ALTANT, an Ozonated Alcohol Disinfectant.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
24 Sep 2020
Historique:
pubmed: 1 5 2020
medline: 28 4 2021
entrez: 1 5 2020
Statut: ppublish

Résumé

Seven human mastadenovirus (HAdV) species (A-G) are known with more than 100 reported types. HAdV is highly resistant to common hand sanitizers. Epidemic keratoconjunctivitis and pharyngoconjunctival fever are caused by HAdV, which can be explosively transmitted in a confined space, resulting in outbreaks, such as nosocomial infections. Given the absence of an antiviral agent against the HAdV infection, it is important to prevent the spread of the infection by using disinfectants. Ozone has already been well-known for its bactericidal and virucidal effects. ALTANT is an ozonated alcohol preparation developed by E-TECH Co., Ltd. (Kobe, Hyogo, Japan). In this study, we mixed ALTANT with different HAdV types at a ratio of 9:1 and determined HAdV viability after instantaneous reactions for varying periods (flash to 5 minutes) using the TCID50 assay. The assay results demonstrated that the HAdV viability decreased by 1/10 to 1/100 within 1 minute after the reaction; additionally, slight differences in the reactivity were observed among the HAdV types. HAdV viability decreased by a factor of > 4log

Identifiants

pubmed: 32350225
doi: 10.7883/yoken.JJID.2020.058
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Disinfectants 0
Ethanol 3K9958V90M
Ozone 66H7ZZK23N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-353

Auteurs

Nozomu Hanaoka (N)

Laboratory Diagnosis Division, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Naomi Nojiri (N)

Laboratory Diagnosis Division, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Kenichiro Takahashi (K)

Laboratory Diagnosis Division, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Eiichi Yoshida (E)

E-TECH Co., Ltd., Japan.

Tsuguto Fujimoto (T)

Laboratory Diagnosis Division, Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH